Dear AuntMinnie Member,
Brain metastases are the most common type in adults, and their numbers are increasing, in part because of better detection of small lesions. Stereotactic radiotherapy is the treatment of choice for managing these tumors, but some lesions recur. Unfortunately, it can be difficult at the treatment planning stage to predict which of these lesions are likely to return.
In this edition of our MRI content area newsletter, we're highlighting a study that identified MR imaging biomarkers that appear to help predict which patients are at a higher risk of recurrence. Click here for the full story.
Once you've read our featured article, check out more of our coverage of research about the many uses of brain MRI, from how functional MRI indicates that some unresponsive patients can still perform cognitive tasks and how the modality shows that even mild traumatic brain injury can have far-reaching effects on brain health to how advanced MRI neuroimaging can change the management of brain cancer.
Next, take a look at our articles regarding the use of AI with cardiovascular MRI to predict patients' heart failure risk, how AI performs comparably to radiologists for identifying prostate cancer on MRI, and how MRI enterography can help assess Crohn's disease.
Finally, click on the links below for stories on the following topics:
- How far women need to travel for breast MRI versus mammography
- MRI's role at the recent Summer Olympics
- Cardiovascular MRI and environmental sustainability
- Multiparametric MRI-guided targeted biopsy for detecting prostate cancer subtypes
- The use of OpenAI's GPT-4 AI model to generate summaries from MR imaging of disease course in glioblastoma patients
Our MRI content area keeps you current on the modality's many benefits. We invite you to check it out regularly, and as always, if you have MRI topics you'd like us to consider, please contact me.
